Hims & Hers has acquired YourBio Health for an undisclosed amount, integrating an innovative medical device company into its operations. YourBio Health, formerly SeventhSense Biosystems, is known for advancing blood collection through its disruptive TAP® device. This push-button technology allows patients to comfortably collect blood samples at home by simply placing the device on their upper arm and pressing a button, eliminating the need for traditional needle-based draws that often cause anxiety and require in-person visits.
The acquisition is strategically aimed at enhancing Hims & Hers’ ability to provide convenient, patient-centric healthcare solutions. By integrating YourBio Health’s virtually painless, at-home blood collection capabilities, Hims & Hers can streamline diagnostic processes, making health monitoring more accessible and less intimidating for patients. The TAP device, featuring HALO™ technology with microneedles thinner than an eyelash, significantly improves the patient experience compared to venipuncture or fingerstick methods.
This move is expected to create significant synergies, allowing Hims & Hers to offer more comprehensive at-home diagnostic services. The ability to collect blood samples without a trip to a lab or a traditional needle draw removes a substantial barrier for many individuals, fostering better patient engagement and adherence to medical treatments. This integration supports a decentralized healthcare model, empowering patients with greater control over their health management.
Looking ahead, the combined entity is poised to accelerate the shift towards convenient and personalized healthcare delivery. By leveraging YourBio Health's innovative technology, Hims & Hers aims to provide a more integrated and comfortable experience for individuals managing their health from home, ultimately improving patient outcomes through enhanced accessibility and ease of use.